UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
TIAN RUIXIANG Holdings Ltd.
(Name of Issuer)
Class A ordinary share, par value $0.005 per share
(Title of Class of Securities)
G8884K128
(CUSIP Number)
Sheng Xu
Room 1001, 10 / F, No. 25, North East Third Ring Road,
Chaoyang District, Beijing,
The People’s Republic of China
86-13501205319
(Name,... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a - 101)
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a - 6(e)(2)) ☐ ... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-32751
GRUPO AEROPORTUARIO DEL PACÍFICO S.A.B. DE C.V.(PACIFIC AIRPORT GROUP)(Translation of registrant's name into English)
México(Jurisdiction of incorporation or organization)
Avenida Mariano Otero No.... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No.1)*
TIAN RUIXIANG Holdings Ltd.
(Name of Issuer)
Class A ordinary share, par value $0.025 per share
Class B ordinary share, par value $0.025 per share
(Title of Class of Securities)
G8884K128
(CUSIP Number)
Sheng Xu
Room 1001, 10 / F, No. 25, North East Third Ring Road,
Chaoyang... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K DR REDDYS LABORATORIES For: Jun 10
-
Form 425 DIAMOND OFFSHORE DRILLIN Filed by: Noble Corp plc
-
Form DEFA14A Zevia PBC
-
Form 8-K Noble Corp plc For: Jun 10
-
Form 8-K Larimar Therapeutics, For: Jun 10
-
Form 8-K NEXT-ChemX Corporation. For: May 29
-
Form 10-D First National Master For: May 31
-
Form S-1/A High Roller Technologies
-
Form 424B5 Gryphon Digital Mining,
-
Form 8-K J.Jill, Inc. For: Jun 06
-
Form 4 RESEARCH FRONTIERS INC For: Jun 07 Filed by: Daigle Darryl
-
Form DEFR14A 5E Advanced Materials,
-
Form 8-K Taylor Morrison Home For: Jun 07
-
Form F-1/A XCHG Ltd
-
Form 6-K TAT TECHNOLOGIES LTD For: Jun 10
-
Form 8-K Synchrony Financial For: Jun 10
-
Form C Bracketology.tv, Inc.
-
Form DEFA14A ICC Holdings, Inc.
-
Form D/A iCapital - Rialto Real
-
Form PRE 14A Presto Automation Inc. For: Jun 07
-
Form 10-Q URANIUM ENERGY CORP For: Apr 30
-
Form S-1 CNS Pharmaceuticals,
-
Form S-1 Spectaire Holdings Inc.
-
Form N-CEN PFS FUNDS For: Mar 31
-
Form 8-K Artificial Intelligence For: Jun 10
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Myrtelle Inc.
-
Form 8-K PROCACCIANTI HOTEL REIT, For: Jun 06
-
Form EFFECT Tidal Trust II
-
Form EFFECT WillScot Mobile Mini
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form EFFECT Alpha Cognition Inc.
-
Form EFFECT Fusion Pharmaceuticals
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form EFFECT Fusion Pharmaceuticals
-
Form EFFECT Business First Bancshare
-
Form EFFECT MicroCloud Hologram Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form EFFECT Creative Media & Communi
-
Form D/A Capital Fund II, LLC
-
Form QUALIF Green Star Products,
-
Form 425 SOUTHWESTERN ENERGY CO Filed by: CHESAPEAKE ENERGY CORP
-
Form DEFA14A Quanex Building Products
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form EFFECT Karyopharm Therapeutics
-
Form EFFECT NEWMARK GROUP, INC.
-
Form EFFECT Calumet, Inc. /DE
-
Form EFFECT Quantum Energy Corp/TA
-
Form EFFECT Fusion Pharmaceuticals
-
Form EFFECT Universe Pharmaceuticals